image credit: Vecteezy

Amid ‘reshoring’ efforts, central Virginia looks to bolster drug supply strength

October 7, 2021


Efforts to “reshore” drug manufacturing and address supply shortages in the U.S. have trickled down to central Virginia, where public and private partners have pledged $2.5 million in seed money for an industry accelerator.

Activation Capital is launching the cluster accelerator focused on advanced pharmaceutical manufacturing and R&D in the central Virginia area that includes Petersburg, Virginia, and Richmond, Virginia.

The initiative is backed by public and private sector organizations involved in the region’s pharmaceutical R&D, manufacturing, employment and supply chain development.

Read More on FiercePharma